Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few ...

Sign In We don’t recognize that sign in. Your username maybe be your email address. Passwords are 6-20 characters with at least one number and letter. We still don’t recognize that sign in.